SCHEMBL7308043

SCHEMBL7308043

CC(C)(C)ONC(=O)CC1(Sc2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 12/20 0.46
MMP13 P45452 8/20 0.41
MMP14 P50281 5/20 0.41
MMP2 P08253 5/20 0.41
MMP9 P14780 5/20 0.41
MMP3 P08254 4/20 0.41
MMP8 P22894 4/20 0.41
MMP7 P09237 2/20 0.41
ABCB11 O95342 1/20 0.41
MMP10 P09238 1/20 0.41
ADAM17 P78536 1/20 0.41
ALDH1A1 P00352 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
P2RX7 Q99572 1/20 0.34
ATF4 P18848 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7311858 0.91 MMP1 (0.45) MMP1MMP13MMP14MMP2MMP9
SCHEMBL7300368 0.90 MMP1 (0.40) MMP1MMP13MMP14MMP2MMP9
SCHEMBL7301981 0.86 MMP1 (0.61) MMP1MMP13MMP14MMP2MMP9
SCHEMBL7304251 0.82 MMP1 (0.47) MMP1MMP13MMP14MMP2MMP9
SCHEMBL7299168 0.81 LMNA (0.39) MMP1MMP13MMP2ALDH1A1HPGD
SCHEMBL7309991 0.80 LMNA (0.41) MMP1MMP13MMP2ALDH1A1HPGD
SCHEMBL7302785 0.78 MMP1 (0.76) MMP1MMP13MMP14MMP2MMP9
SCHEMBL7306527 0.77 NPC1 (0.36) MMP1MMP13MMP14MMP2MMP9
SCHEMBL7307984 0.77 ALDH1A1 (0.39) ALDH1A1L3MBTL1
SCHEMBL7303599 0.76 MMP1 (0.49) MMP1MMP13MMP14MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed